What is Compliance and Why is it Important?
By Michelle onThis blog written by Tatiana Foroud, Alyssa Reimer, Claire Wegel, and Schuyler Fox outlines compliance and its importance, specifically in regards to the GP2 initiative.
Understanding GWAS
By Michelle onThis blog written by Hampton Leonard, Dr. Mike Nalls, Yeajin Song, and Dan Vitale explains GWAS.
Parkinson’s Disease Genetics: Cause, Risk, or Protection?
By Michelle onThis blog written by Dr. Christine Klein discusses the genetics of Parkinson's disease.
Decoding the Aliens Within
By Michelle onThis blog written by Benjamin Stecher, a patient advocate and author, shows insight into his life as an individual with PD and what genetic insights can provide to understanding PD.
Open Science Opens Doors
By Michelle onThis blog written by Dr. Bradford Casey describes the value of open science.
A letter to the patient community from Randy Schekman, ASAP Scientific Director
By Michelle onThis blog written by Dr. Randy Schekman and Benjamin Stecher describes the motivation and beginnings of the ASAP initiative. It also includes a letter written to the PD comunity by Dr. Schekman.
A Blueprint for Training and Development in GP2
By Michelle onThis blog written by Dr. Alastair Noyce and Dr. Sara Bandres-Ciga discusses GP2's plan to train students and investigators and the new considerations as a result of the COVID-19 pandemic.
Why study disease in different populations?
By Blythe Lloyd onThis blog was written by Dr.Ignacio Fernandez Mata and discusses why diversity should be considered in PD research.
Increasing Underrepresented Hispanic Participation in Parkinson’s and Genomic Research Through the LARGE-PD Study
By Michelle onThis blog written by Dr. Ignacio Fernandez Mata, Dr. Philippe Salles, Shilpa Rao, Miguel Inca Martinez, Nicolas Gutierrez, and Thiago Peixoto describes the LARGE-PD study and how it is increasing hispanic representation in PD research.